Our trial at Nutrition 2024

Hydrogen and PQQ for mild cognitive impairment

Our recent research on the impact of dihydrogen-pyrroloquinoline quinone (PQQ) supplementation in elderly individuals was presented at the annual conference of the American Society for Nutrition in Chicago earlier this week. During our presentation, we had the opportunity to meet several colleagues, including Dr. Timmcke from Calerie Health, and discuss dihydrogen-PQQ as a potential dietary intervention for enhancing mental orientation and brain metabolism in individuals with age-related mild cognitive decline. The full study is available in The Journal of Nutrition, Health and Aging.

Share this post